Sheridan, WY, December 28, 2019 --(PR.com
)-- The study comparing hospital care at home versus hospital admission for patients aged 65 years or older with community-acquired pneumonia, chronic heart failure, chronic obstructive pulmonary disease, or cellulitis, found that home hospital care met quality standards and resulted in shorter stays (3.2 vs. 4.9 days) and lower mean costs ($5081 vs. $7480). A systematic review and meta-analysis of 10 randomized controlled studies found similar outcomes - and notably a survival advantage at 6 months - with hospital care at home.
Building on this information HomeHealth24x7®, a leading Home Health Care provider, recently completed a trial of the CENSON Care Remote Patient Monitoring platform, which allows the agency to receive patient vitals and other relevant data 24 hours a day.
HomeHealth24x7® CEO Daniel Lantape commented, "Hospital at Home requires substantial agency planning, including home monitoring systems and support technology, staffing, ancillary services, and point-of-care testing for the patients homes. Nevertheless, agencies might benefit from systematically integrating a Hospital at Home model to lower hospital readmissions and costs."
The HomeHealth24x7® agency trial confirmed previous trial results with patients cared for utilizing Hospital at Home spent significantly less of their care time sedentary (12% vs. 23%) or lying down (32% vs. 66%), used significantly fewer healthcare resources (e.g., lab orders, radiologic studies, specialty consultations); and were significantly less likely to require readmissions within 30 days (7% vs. 23%).
"We are excited to offer this program through many of our locations nationwide commencing early 2020," stated Mr Lantape.
HomeHealth24x7® is a national, franchise based, home health care agency offering a comprehensive range of chronic care solutions, including Hospital and Home.